Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 78, 2018 - Issue 1-2
Submit an article Journal homepage
415
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of a faecal dysbiosis test for irritable bowel syndrome in subjects with and without obesity

Martin AasbrennDepartment of Surgery, Innlandet Hospital Trust, Gjøvik, Norway; ;Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-3637-5763View further author information
ORCID Icon,
Jørgen ValeurUnger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway; View further author information
&
Per G. FarupDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; ;Department of Research, Innlandet Hospital Trust, Brumunddal, NorwayView further author information
Pages 109-113 | Received 06 Jul 2017, Accepted 16 Dec 2017, Published online: 22 Dec 2017

References

  • Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017;376:2566–2578.
  • Camilleri M. Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders. Aliment Pharmacol Ther. 2015;42:818–828.
  • Sood R, Gracie DJ, Law GR, et al. Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers. Aliment Pharmacol Ther. 2015;42:491–503.
  • Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369–2379.
  • GA-map TM Dysbiosis Test [Internet]. Oslo: Genetic Analysis; 2016 [cited 2017 Nov 11]. Available from: http://www.genetic-analysis.com/ga-map-dysbiosis-test
  • Major G, Spiller R. Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes. 2014;21:15–21.
  • Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541–546.
  • Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55–60.
  • Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016;8:67.
  • Zhuang X, Xiong L, Li L, et al. Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32:28–38.
  • Casen C, Vebø HC, Sekelja M, et al. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther. 2015;42:71–83.
  • Bennet SMP, Böhn L, Störsrud S, et al. Multivariate modelling of faecal bacterial profilse of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut. 2017. doi: 10.1136/gutjnl-2016-313128.
  • Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2009;18:190–195.
  • NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956–961.
  • Ricanek PV, Vatn S, Kalla R, et al. The Ibd-Character Consortium. Microbiota Alterations in Treatment Naïve IBD and Non-IBD Patients - the EU IBD-Character Project. United European Gastroenterol J. 2016;4:A95.
  • Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491.
  • Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary Pharmacol Ther. 1997;11:395–402.
  • Sauar J, Halvorsen F, Corwin C, Olafsson S. Dysbiosis and stability over two years in patients with irritable bowel syndrome. United European Gastroenterology J. 2016;4(Supplement 1):A524.
  • Falony G, Joossens M, Vieira-Silva S, et al. Population-level analysis of gut microbiome variation. Science. 2016;352:560–564.
  • Portney LG, Watkins MP. Foundations of Clinical Research Applications to Practice. Upper Saddle River (NJ): Pearson International Edition 2009. Statistical measures of validity, p. 619–658.
  • Vebø HC, Sekelja M, Nestestog R, et al. Temporal development of the infant gut microbiota in immunoglobulin E-sensitized and nonsensitized children determined by the GA-map infant array. Clin Vaccine Immunol. 2011;18:1326–1335.
  • Magnusson MK, Strid H, Sapnara M, et al. Anti-TNF therapy response in patients with ulcerative colitis is associated with colonic antimicrobial peptide expression and microbiota composition. ECCOJC. 2016;10:943–952.
  • Hansen TH, Gøbel RJ, Hansen T, et al. The gut microbiome in cardio-metabolic health. Genome Med. 2015;7:33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.